Autopsy report · NCT01492465

Single Ascending Dose Trial in Patients With Type 2 Diabetes

“Decision by Sponsor”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 11 months before it stopped.
• 47 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Amgen

Sponsor type

Industry

Conditions

Diabetes Mellitus

Interventions

AMG 876

Participants

47

Sites

3

Countries

United States

Trials that died the same way

• The Effect of a Probiotic Strain on Aspirin-induced GI Damage
  “Decision made by Sponsor” (98% match in meaning)
• A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)
  “Sponsor Decision” (97% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.